Citations

Mayo Clinic

Showing 10 of 108585 citations.

Exploring the Potential of Chatbots in Critical Care Nephrology
Suppadungsuk, Supawadee , Miao, Jing , Krisanapan, Pajaree , Kashani, Kianoush , Cheungpasitporn, Wisit , Miao, Jing , Krisanapan, Pajaree , Kashani, Kianoush B , Cheungpasitporn, Wisit , Suppadungsuk, Supawadee , Thongprayoon, Charat , Qureshi, Fawad

Medicines | October 21, 2023 | Volume: 10 | Issue: 10 | Pages: 58

10.3390/medicines10100058 | PMID 37887265 Get It

The exponential growth of artificial intelligence (AI) has allowed for its integration into multiple sectors, including, notably, healthcare. Chatbots have emerged as a pivotal resource for improving patient outcomes and assisting healthcare practitioners through various AI-based technologies. In critical care, kidney-related conditions play a significant role in determining patient outcomes. This article examines the potential for integrating chatbots into the workflows of critical care nephrology to optimize patient care. We detail their specific applications in critical care nephrology, such as managing acute kidney injury, alert systems, and continuous renal replacement therapy (CRRT); facilitating discussions around palliative care; and bolstering collaboration within a multidisciplinary team. Chatbots have the potential to augment real-time data availability, evaluate renal health, identify potential risk factors, build predictive models, and monitor patient progress. Moreover, they provide a platform for enhancing communication and education for both patients and healthcare providers, paving the way for enriched knowledge and honed professional skills. However, it is vital to recognize the inherent challenges and limitations when using chatbots in this domain. Here, we provide an in-depth exploration of the concerns tied to chatbots’ accuracy, dependability, data protection and security, transparency, potential algorithmic biases, and ethical implications in critical care nephrology. While human discernment and intervention are indispensable, especially in complex medical scenarios or intricate situations, the sustained advancements in AI signal that the integration of precision-engineered chatbot algorithms within critical care nephrology has considerable potential to elevate patient care and pivotal outcome metrics in the future.
Artificial intelligence-enabled operating room data analysis: Current and future prospects for enhancing surgical safety
Tetteh, Emmanuel , Wang, Tianke, Norasi, Hamid , Kim, Joseph , Tetteh, Emmanuel , Kim, Joseph Y , Wang, Tianke , Cleary, Sean P. , Hallbeck, M. Susan

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 21, 2023 | Volume: 67 | Issue: 1 | Pages: 2079-2081

10.1177/21695067231192661 Get It

Despite advances in medical technology, intraoperative adverse events (IAE) continue to occur in hospital’s complex systems. Current approaches to understanding and mitigating IAEs rely on retrospective data analyses to recognize the series of events leading to an IAE. This paper discusses current challenges and highlights the potential of the Operating Room Blackbox (ORBB) system use to enhance patient safety.
MicroRNA-30d and -483-3p for Bi-Ventricular Remodelling and miR-126-3p for Pulmonary Hypertension in Advanced Heart Failure
Sciacca, Sergio , Scardulla, Cesare, Cipriani, Manlio, Oh, Jae K. , Pasta, Salvatore , Maalouf, Joseph F., Bellavia, Diego , Pasta, Salvatore , Gallo, Alessia , Agnese, Valentina , Cipriani, Manlio , Pilato, Michele , Conaldi, Pier Giulio

ESC Heart Failure | October 21, 2023 | Volume: 11 | Issue: 1 | Pages: 155-166

10.1002/ehf2.14546 | PMID 37864482 Get It

Abstract Aims MicroRNAs play a role in pathogenic mechanisms leading to heart failure. We measured a panel of 754 miRNAs in the myocardial tissue and in the serum of patients with heart failure with reduced ejection fraction due to dilatative idiopathic cardiomyopathy (DCM, N = 10) or ischaemic cardiomyopathy (N = 3), referred to left ventricular assist device implant. We aim to identify circulating miRNAs with high tissue co-expression, significantly associated to echocardiographic and haemodynamic measures. Methods and results We have measured a panel of 754 miRNAs in the myocardial tissue [left ventricular (LV) apex] and in the serum obtained at the same time in a well selected study population of end-stage heart failure with reduced ejection fraction due to either DCM or ischaemic cardiomyopathy, referred to continuous flow left ventricular assist device implant. We observed moderate agreement for miR-30d, miR-126-3p, and miR-483-3p. MiR-30d was correlated to LV systolic as well as diastolic volumes (r = 0.78, P = 0.001 and r = 0.80, P = 0.005, respectively), while miR-126-3p was associated to mPAP and PCWP (r = −0.79, P = 0.007 and r = −0.80, P = 0.005, respectively). Finally, serum miR-483-3p had an association with right ventricular end diastolic diameter (r = −0.73, P = 0.02) and central venous pressure (CVP) (r − 0.68 p 0.03). Conclusions In patients with DCM, few miRNAs are co-expressed in serum and tissue: They are related to LV remodelling (miR-30d), post-capillary pulmonary artery pressure (miR-126-3p), and right ventricular remodelling/filling pressures (miR-483-3p). Further studies are needed to confirm their role in diagnosis, prognosis or as therapeutic targets in heart failure with reduced ejection fraction.
Membranous nephropathy—diagnosis and identification of target antigens
Sethi, Sanjeev , Fervenza, Fernando C. , Fervenza, Fernando C

Nephrology Dialysis Transplantation | October 21, 2023 | Volume: 39 | Issue: 4 | Pages: 600-606

10.1093/ndt/gfad227 | PMID 37863839 Get It

ABSTRACT Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. MN is characterized by subepithelial accumulation of immune complexes along the glomerular basement membrane. The immune complexes are composed of immunoglobulin G and a target antigen. PLA2R is the target antigen in approximately 60% of MN cases, and MN is traditionally classified as PLA2R-positive or PLA2R-negative MN. Over the last 7 years, additional target antigens have been identified, which have specific disease associations, distinctive clinical and pathologic findings, and therapeutic implications. The newly discovered target antigens include NELL1, EXT1/EXT2, NCAM1, SEMA3B, PCDH7, FAT1, CNTN1, NTNG1, PCSK6 and NDNF. To group all these antigens into a generic ‘PLA2R-negative’ MN group is imprecise and un-informative. We propose a logical approach for detection of the target antigen which includes (i) currently available serology-based testing to detect anti-PLA2R and anti-THSD7A antibodies; and (ii) kidney biopsy testing to detect the target antigens. Determination of the antigen on kidney biopsy can be done by immunohistochemistry or immunofluorescence studies. Alternatively, laser capture microdissection (LCM) of glomeruli followed by mass spectrometry (MS) can be used to identify a target antigen. LCM/MS has the advantage of being a one-stop test and is particularly useful for detection of rare target antigens. At the current time, while it is possible to detect the newer antigens by immunohistochemistry/immunofluorescence/LCM/MS, serology-based tests to detect serum antibodies to the new antigens are not yet available. It is critical that serology-based tests should be developed not just for accurate diagnosis, but as a guide for treatment. We review the current methodology and propose an algorithm for diagnosis and detection of target antigens in MN that may shape the current practice in the future. Membranous nephropathy (MN) results from accumulation of subepithelial immune complexes along the glomerular basement membrane.PLA2R is the most common target antigen, but newly discovered target antigens have filled the void of PLA2R-negative MN.MN associated with the newly discovered target antigens have distinctive clinical and pathologic findings, treatment and prognostic implications. These include NELL1, EXT1/EXT2, NCAM1, PCDH7, SEMA3B, CNTN1, FAT1, NDNF and PCSK6.Immunohistochemistry/immunofluorescence methodology is currently in use for detecting target antigens in kidney biopsy tissue, although we anticipate laser capture microdissection of glomeruli followed by mass spectrometry will become available soon.Serologic testing is currently available for only detecting antibodies to PLA2R and THSD7A. It is critical that serologic tests become available for detecting antibodies to the newly discovered antigens.
Neck extensor fatigue: Comparing the effect of 45 degrees of neck flexion to the effect of 45 degrees of trunk flexion
Norasi, Hamid , Hallbeck, M. Susan , Mirka, Gary A.

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 21, 2023 | Volume: 67 | Issue: 1 | Pages: 2353-2358

10.1177/21695067231192696 Get It

The neck muscle fatigue and subjective discomfort due to neck postural exposure was evaluated. Ten male participants were asked to hold one of the two static neck postural exposures for 30 minutes (one condition per day): 1) Neck flexion (N-45) where head and neck were flexed 45º relative to trunk while the participant was standing upright, and 2) Trunk flexion (T-45) where head and neck were not flexed relative to trunk, but trunk was flexed 45º. Surface electromyography was used to collect muscle activity of neck extensors. T-45 caused higher fatigue in neck extensor muscles (p=0.0229) and higher neck subjective discomfort (p=0.0088) compared to N-45, but the long-term effects of these two conditions are not clear because of the difference in the role of passive tissues. We recommend that work assessment tools consider both measures of neck postural exposure (neck flexion and trunk flexion) in their assessment tools.
Surgical management of malignant melanotic nerve sheath tumors: an institutional experience and systematic review of the literature
Johnson, Sarah E. , Ghanem, Marc , Michaelides, Loizos , Nieves, Antonio Bon, Marsh, W. Richard , Currier, Bradford L. , Atkinson, John L. D., Spinner, Robert J. , Bydon, Mohamad , Bon‐Nieves, Antonio , El-Hajj, Victor Gabriel , Bon Nieves, Antonio, Bon-Nieves, Antonio A , Ghaith, Abdul Karim , Akinduro, Oluwaseun O. , Biase, Gaetano De

Journal of Neurosurgery: Spine | October 21, 2023 | Volume: 40 | Issue: 1 | Pages: 28-37

10.3171/2023.8.spine23427 | PMID 37862711 Get It

OBJECTIVE Malignant melanotic nerve sheath tumors are rare tumors characterized by neoplastic melanin-producing Schwann cells. In this study, the authors report their institution’s experience in treating spinal and peripheral malignant melanotic nerve sheath tumors and compare their results with the literature. METHODS Data were collected from 8 patients who underwent surgical treatment for malignant melanotic nerve sheath tumors between 1996 and 2023 at Mayo Clinic and 63 patients from the literature. Time-to-event analyses were performed for the combined group of 71 cases to evaluate the risk of recurrence, metastasis, and death based on tumor location and type of treatment received. Unpaired 2-sample t-tests and Fisher’s exact tests were used to determine statistical significance between groups. RESULTS Between 1996 and 2023, 8 patients with malignant melanotic nerve sheath tumors underwent surgery at the authors’ institution, while 63 patients were identified in the literature. The authors’ patients and those in the literature had the same mean age at diagnosis (43 years). At the authors’ institution, 5 patients (63%) experienced metastasis, 6 patients (75%) experienced long-term recurrence, and 5 patients (62.5%) died. In the literature, most patients (60.3%) were males, with a peak incidence between the 4th and 5th decades of life. Nineteen patients (31.1%) were diagnosed with Carney complex. Nerve root tumors accounted for most presentations (n = 39, 61.9%). Moreover, 24 patients (38.1%) had intradural lesions, with 54.2% (n = 13) being intramedullary and 45.8% (n = 11) extramedullary. Most patients underwent gross-total resection (GTR) (n = 41, 66.1%), followed by subtotal resection (STR) (n = 12, 19.4%), STR with radiation therapy (9.7%), and GTR with radiation therapy (4.8%). Sixteen patients (27.6%) experienced metastasis, 23 (39.7%) experienced recurrence, and 13 (22%) died. Kaplan-Meier analyses showed no significant differences among treatment approaches in terms of recurrence-free, metastasis-free, and overall survival (p > 0.05). Similar results were obtained when looking at the differences with respect to intradural versus nerve root location of the tumor (p > 0.05). CONCLUSIONS Malignant melanotic nerve sheath tumors are rare tumors with a high potential for malignancy. They carry a dismal prognosis, with a pooled local recurrence rate of 42%, distant metastasis rate of 27%, and mortality rate of 26%. The findings from this study suggest a trend favoring the use of GTR alone or STR with radiation therapy over STR alone. Mortality was similar regardless, which highlights the need for the development of effective treatment options to improve survival in patients with melanotic schwannomas.
Stent-assisted Woven EndoBridge device for the treatment of intracranial aneurysms: an international multicenter study
Diestro, Jose Danilo Bengzon , Adeeb, Nimer , Regenhardt, Robert W. , Guenego, Adrien , Lay, Sovann V. , Balushi, Ali Al , Premat, Kévin , Namaani, Kareem El, Möhlenbruch, Markus , Foreman, Paul M. , Vachhani, Jay A. , Župančić, Vedran , Rai, Hamid, Tutino, Vincent M. , Mirshahi, Shervin , Ghozy, Sherief , Rabinov, James D. , Ren, Yifan , Goren, Oded , Michelozzi, Caterina , Elens, Stéphanie , Starke, Robert M. , Nguyên, Anh , Jones, Jesse , Psychogios, Marios, Spears, Julian , Marotta, Thomas R. , Bres-Bullrich, Maria , Mayich, Michael , Salem, Mohamed M. , Burkhardt, Jan‐Karl , Jankowitz, Brian T. , Ulfert, Christian , Lubicz, Boris , Puri, Ajit S , Pero, Guglielmo , Asadi, Hamed , Ducruet, Andrew F. , Albuquerque, Felipe C , Patel, Nirav J. , Kan, Peter , Kalousek, Vladimir , Lylyk, Pedro , Boddu, Srikanth , Stapleton, Christopher J. , Knopman, Jared , Tjoumakaris, Stavropoula , Clarençon, Frédéric , Patel, Aman B. , Tawk, Rabih, Ghozy, Sherief , Diestro, Jose Danilo B , Shotar, Eimad , Tutino, Vincent M , Nguyen, Anh , Pero, Guglielmo , Kalousek, Vladimir , Regenhardt, Robert W , Ulfert, Christian , Lay, Sovann V , Burkhardt, Jan‐Karl , Dibas, Mahmoud , Vranic, Justin E. , Renieri, Leonardo , Shotar, Eimad , Saliou, Guillaume , Lylyk, Iván , Hafeez, Muhammad Ubaid , Rutledge, Caleb , Harker, Pablo , Alotaibi, Naif M. , Schirmer, Clemens M. , Piano, Mariangela , Kühn, Anna Luisa , Hassan, Ameer E , Salehani, Arsalaan , Psychogios, Marios‐Nikos , Mendes Pereira, Vitor , Parra-Fariñas, Carmen , Bullrich, María Bres , Domingo, Ricardo A. , Huynh, Thien , Tawk, Rabih G. , Panni, Pietro , Griessenauer, Christoph J. , Siddiqui, Adnan H. , Jabbour, Pascal , Limbucci, Nicola , Aziz‐Sultan, Mohammad Ali , Cuellar, Hugo , Cognard, Christophe , Dmytriw, Adam A.

Journal of Neurosurgery | October 21, 2023 | Volume: 140 | Issue: 4 | Pages: 1071-1079

10.3171/2023.8.jns235 | PMID 37862717 Get It

OBJECTIVE The Woven EndoBridge (WEB) device is an intrasaccular flow disruptor designed for wide-necked bifurcation aneurysms. These aneurysms may require the use of a concomitant stent. The objective of this study was to determine the clinical and radiological outcomes of patients undergoing stent-assisted WEB treatment. In addition, the authors also sought to determine the predictors of a concomitant stent in aneurysms treated with the WEB device. METHODS The data for this study were taken from the WorldWideWEB Consortium, an international multicenter cohort including patients treated with the WEB device. Aneurysms were classified into two groups based on treatment: stent-assisted WEB and WEB device alone. The authors compared clinical and radiological outcomes of both groups. Univariable and multivariable binary logistic regression analyses were performed to determine factors that predispose to stent use. RESULTS The study included 691 intracranial aneurysms (31 with stents and 660 without stents) treated with the WEB device. The adequate occlusion status did not differ between the two groups at the latest follow-up (83.3% vs 85.6%, p = 0.915). Patients who underwent stenting had more thromboembolic (32.3% vs 6.5%, p < 0.001) and procedural (16.1% vs 3.0%, p < 0.001) complications. Aneurysms treated with a concomitant stent had wider necks, greater heights, and lower dome-to-neck ratios. Increasing neck size was the only significant predictor for stent use. CONCLUSIONS This study demonstrates that there is no difference in the degree of aneurysm occlusion between the two groups; however, complications were more frequent in the stent group. In addition, a wider aneurysm neck predisposes to stent assistance in WEB-treated aneurysms.
Airway Versus Transpulmonary Driving Pressures During Pressure Support Ventilation in ARDS
Zheng, Christopher Z., Cortes-Puentes, Gustavo A.

Respiratory Care | October 20, 2023 | Volume: 68 | Issue: 11 | Pages: 1606-1608

10.4187/respcare.11428 | PMID 37863827 Get It

Divergent Skeletal Muscle Metabolomic Signatures of Different Exercise Training Modes Independently Predict Cardiometabolic Risk Factors
Kumar, Arathi Prabha, Dasari, Surendra , Klaus, Katherine A. , Nair, K. Sreekumaran , Pataky, Mark W, Kumar, A Aneesh, Nair, K Sreekumaran , Asokan, Aneesh K , Pataky, Mark W , Gaul, David A. , Moore, Samuel G. , Robinson, Matthew M. , Kumar, Ashok , Fernández, Facundo Machado

Diabetes | October 20, 2023 | Volume: 73 | Issue: 1 | Pages: 23-37

10.2337/db23-0142 | PMID 37862464 Get It

We investigated the link between enhancement of SI (by hyperinsulinemic–euglycemic clamp) and muscle metabolites after 12 weeks of aerobic (high-intensity interval training [HIIT]), resistance training (RT), or combined training (CT) exercise in 52 lean healthy individuals. Muscle RNA sequencing revealed a significant association between SI after both HIIT and RT and the branched-chain amino acid (BCAA) metabolic pathway. Concurrently with increased expression and activity of branched-chain ketoacid dehydrogenase enzyme, many muscle amino metabolites, including BCAAs, glutamate, phenylalanine, aspartate, asparagine, methionine, and γ-aminobutyric acid, increased with HIIT, supporting the substantial impact of HIIT on amino acid metabolism. Short-chain C3 and C5 acylcarnitines were reduced in muscle with all three training modes, but unlike RT, both HIIT and CT increased tricarboxylic acid metabolites and cardiolipins, supporting greater mitochondrial activity with aerobic training. Conversely, RT and CT increased more plasma membrane phospholipids than HIIT, suggesting a resistance exercise effect on cellular membrane protection against environmental damage. Sex and age contributed modestly to the exercise-induced changes in metabolites and their association with cardiometabolic parameters. Integrated transcriptomic and metabolomic analyses suggest various clusters of genes and metabolites are involved in distinct effects of HIIT, RT, and CT. These distinct metabolic signatures of different exercise modes independently link each type of exercise training to improved SI and cardiometabolic risk. Article Highlights We aimed to understand the link between skeletal muscle metabolites and cardiometabolic health after exercise training. Although aerobic, resistance, and combined exercise training each enhance muscle insulin sensitivity as well as other cardiometabolic parameters, they disparately alter amino and citric acid metabolites as well as the lipidome, linking these metabolomic changes independently to the improvement of cardiometabolic risks with each exercise training mode. These findings reveal an important layer of the unique exercise mode–dependent changes in muscle metabolism, which may eventually lead to more informed exercise prescription for improving SI.
Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study
Beyer, Johanna , Couch, Ronan E. , Ruddy, Kathryn J. , Zeydan, Burcu , Tosakulwong, Nirubol , Lesnick, Timothy G. , Novotny, Paul J. , Kohli, Sadhna , Cerhan, Jane H. , Pruthi, Sandhya , Kantarci, Kejal , Beyer, Joana , Couch, Ronan , Kara, Firat , Pruthi, Sandhya , Kantarci, Kejal , Zeydan, Burcu , Kara, Firat

Medicine | October 20, 2023 | Volume: 102 | Issue: 42 | Pages: e35524

10.1097/md.0000000000035524 | PMID 37861526 Get It

Few proton magnetic resonance spectroscopy studies have explored chemotherapy-related biochemical changes in brain regions. This observational study aimed to longitudinally assess short-term cognitive changes and brain metabolite concentrations in women undergoing chemotherapy for breast cancer. We analyzed 11 women with newly diagnosed stage 1 to 3 breast cancer. Patients were evaluated via objective cognitive testing, and patient self-report tests. Patients were examined using single voxel proton magnetic resonance spectroscopy in the medial frontal cortex, posterior cingulate gyrus, and left thalamus at baseline and after the completion of chemotherapy on a 1.5 Tesla scanner. At the posttreatment evaluation as compared to baseline, 7 of the 10 (70%) patients reported worsening memory on the MD Anderson symptom inventory (annualized change = 1.82 ± 2.88, P = .08), while the delayed recall raw score of the Rey Osterrieth complex figure test did not change from pre- to post-chemotherapy (mean annualized change = 5.00 ± 14.38, P = .30). The annualized change in the creatine concentration in the posterior cingulate gyrus was statistically significant. The annualized change in the MD Anderson symptom inventory was negatively correlated with the annualized change in the medial frontal N-acetylaspartate (Spearman correlation coefficient [rho] = −0.78, P = .01) and positively correlated with the annualized change in the posterior cingulate gyrus creatine (rho = 0.66, P = .04). Annualized changes in the Rey Osterrieth complex figure test were positively correlated with annualized changes in choline (rho = 0.83, P = .01) in the medial frontal cortex, choline (rho = 0.76, P = .04) in the left thalamus, and creatine (rho = 0.73, P = .02) in the medial frontal cortex. Our data suggest that chemotherapy may lead to the worsening of self-reported memory function, which is associated with alterations in brain metabolites.